Management of Hepatitis C Infection
Summary
- Most common adverse events with glecaprevir/pibrentasvir are headache and fatigue[FDA Glecaprevir Pibrentasvir]
- Few serious adverse events and discontinuations related to treatment occurred in clinical trials[Zeuzem 2018; Asselah 2018; Forns 2017; Gane 2016]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content